Artios Pharma
UKEntry
2020
Hold
6yr
Status
Active
Who owns Artios Pharma?
Artios Pharma is currently owned by Sofinnova Partners through Sofinnova Crossover Fund I (2018 vintage), since 2020. Across its history, Artios Pharma has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Sofinnova PartnersSofinnova Crossover Fund I · 2018 · VC
4 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by IP Group, SV Health Managers, Andera Partners and Sofinnova Partners since 2016.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2016 · present
IP GroupActive
2016 · present(10yr) · IP Group (Evergreen) · 2001 · Evergreen
SV Health ManagersActive
2016 · present(10yr) · SV Life Sciences Fund VI · 2015 · Life Sciences VC
Andera PartnersActive
2018 · present(8yr) · BioDiscovery 5 · 2017 · VC
Sofinnova PartnersActive
2020 · present(6yr) · Sofinnova Crossover Fund I · 2018 · VC
More from Sofinnova Crossover Fund I
Other portfolio companies in the same fund.
France
Sweden
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Artios Pharma
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Artios Pharma?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Artios Pharma.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue